Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.

TitleImproving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.
Publication TypeJournal Article
Year of Publication2010
AuthorsLavretsky, H, Siddarth P, Irwin MR
JournalThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Volume18
Issue2
Pagination154-62
Date Published2010 Feb
ISSN1545-7214
KeywordsAged, Aged, 80 and over, Antidepressive Agents, Second-Generation, Anxiety, Caregivers, Citalopram, cognition, Cost of Illness, Dementia, Depression, Double-Blind Method, Female, Humans, Male, Middle Aged, Pilot Projects, Placebos, Quality of Life, Remission Induction, Resilience, Psychological, Stress, Psychological, Treatment Outcome
Abstract

This study examined the potential of an antidepressant drug, escitalopram, to improve depression, resilience to stress, and quality of life in family dementia caregivers in a randomized placebo-controlled double-blinded trial.

DOI10.1002/gps.3790
Alternate JournalAm J Geriatr Psychiatry